ask="1.1300"
ask_size="1600"
average_daily_volume="3930290"
bid="0.6700"
bid_size="5000"
book_value="0.1480"
change="+0.0171"
change_from_200_day_moving_average="0.3171"
change_from_50_day_moving_average="0.1959"
change_from_52_week_high="-0.0595"
change_From_52_week_low="0.4185"
change_in_percent="+2.5022%"
close="0.7005"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.1600"
ebitda="-32.41M"
eps_estimate_current_year="-0.1200"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="-0.0500"
ex_dividend_date="N/A"
float_shares="241890000"
high="0.7200"
high_52_weeks="0.7600"
last_trade_date="3/17/2017"
last_trade_price="0.7005"
last_trade_size="1891027"
last_trade_time="4:00pm"
low="0.6600"
low_52_weeks="0.2820"
market_capitalization="189.88M"
moving_average_200_day="0.3834"
moving_average_50_day="0.5046"
name="Peregrine Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="2.0000"
open="0.6800"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="+82.7045%"
percent_change_from_50_day_moving_average="+38.8308%"
percent_change_from_52_week_high="-7.8289%"
percent_change_from_52_week_low="+148.4043%"
previous_close="0.6834"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.6176"
price_per_sales="3.1661"
revenue="58.51M"
shares_outstanding="271068000"
short_ratio="0.8100"
stock_exchange="NCM"
symbol="PPHM"
volume="4752083"
weeks_range_52="0.2820 - 0.7600"
